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Aromatic Esters of Bicyclic Amines as Antimicrobials against Streptococcus pneumoniae
María de Gracia Retamosa, Roberto Díez-Martínez, Beatriz Maestro,Esther García-Fernµndez, Bas de Waal, E. W. Meijer,P edro García,* and Jesffls M. Sanz* Abstract: Ad ouble approach was followed in the search of novel inhibitors of the surface choline-binding proteins (CBPs) of Streptococcus pneumoniae (pneumococcus) with antimicrobial properties.F irst, al ibrary of 49 rationally-designed esters of alkylamines was screened for their specific binding to CBPs.T he best binders,b eing esters of bicyclic amines (EBAs), were then tested for their in vitro effect on pneumococcal growth and morphology.Second, the efficiency of EBAinduced CBP inhibition was enhanced about 45 000-fold by multivalency effects upon synthesizing ap oly(propylene imine) dendrimer containing eight copies of an atropine derivative.B oth approaches led to compounds that arrest bacterial growth, dramatically decrease cell viability,a nd exhibit ap rotection effect in animal disease models,d emonstrating that the pneumococcal CBPs are adequate targets for the discovery of novel antimicrobials that overcome the currently increasing antimicrobial resistance issues.
Antimicrobial resistance (AMR) to traditional antibiotics constitutes af irst-order problem in current healthcare,a nd may lead to ap ost-antibiotic era in which many common infections would be unable to be effectively treated. [1] Streptococcus pneumoniae is am ajor causative agent of pneumonia, meningitis,a nd otitis media worldwide,w ith an estimated 1.6 million deaths per year.
[2] AMR has had as erious impact on the pneumococcal infections,w hich are increasingly difficult to treat owing to the emergence of resistant strains. [1, 2] Therefore,p rompt actions to attack this problem are needed, including the search for novel compounds directed to new targets common to most pneumococcal isolates. Choline-binding proteins (CBPs) are afamily of bacterial surface-exposed polypeptides that play key cellular roles, such as adhesion to the host, separation of daughter cells,and toxin release. [3] CBPs are organized into afunctional module and ac holine-binding module (CBM), the latter of which is responsible for the attachment to the choline residues present in teichoic and lipoteichoic acids of the bacterial cell wall. [4] CBMs contain 20-amino acid tandem repetitions known as choline-binding repeats (CBRs), which are b-hairpin-loop structures rich in aromatic residues that bind choline through hydrophobic and cation-p interactions. [4] Several choline analogues, [5] and in particular esters of bicyclica mines (EBAs) such as atropine and ipratropium, [5b] are efficient inhibitors of CBPs.T hey arrest pneumococcal growth in vitro and highly decrease cell viability (> 90 %), although at concentrations far from therapeutically acceptable.Onthe other hand, the multivalent display of choline in poly(propylene imine) (PPI) dendrimers exponentially increases its affinity for CBPs, [6] causing inhibition of daughter cell separation after division and favoring phagocytosis by microglial cells. [7] Theaim of our work was the improvement of EBAd ruggability by enhancing their binding to CBPs, following two complementary approaches:the rational design and assay of new EBAderivatives,and the multivalent display of EBAs on the surface of aPPI dendrimer.
Analysis of crystalline complexes between the pneumococcal CBP CbpF and atropine [8] points,a sthe major determinant for stronger EBAb inding,t ot he simultaneous involvement of tryptophan residues in the binding site with the ammonium group in the ligand (through cation-p forces), and with its aromatic moiety (involving T-shaped p-p stacking). Therefore,w es ynthetized al ibrary of 49 derivatives of choline,a tropine,a nd ipratropium, paying special attention to the diversity in the number of aromatic rings and their spatial disposition (Supporting Information, Scheme S1). Relevant compounds displaying the lowest minimal bacterial inhibitory concentrations (MICs) are shown in Scheme 1a.F or ease of synthesis,i pratropium derivatives contain an ethyl N-substituent instead of an isopropyl group.
To screen the library,w ef irst checked the effect of these compounds on the fluorescence anisotropy of the C-LytA-GFP hybrid protein, which contains the CBM of the pneumococcal LytA amidase (C-LytA) fused to the green fluorescent protein (GFP). Previous reports demonstrated that millimolar concentrations of choline induce C-LytA dimerization, 
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Chemie bringing together the GFP moieties and inducing ad ecrease in fluorescence anisotropy as ar esult of energy transfer. [6a] Using this assay,1m m solutions of most EBAs induced ah igher decrease in anisotropy than choline,a tropine,o r ipratropium (Supporting Information, Figure S1 ), leading in some cases to visible aggregation, and suggesting stronger binding to the C-LytA module.M oreover,t hose molecules with two or three aromatic rings display the most remarkable results (Supporting Information, Figure S1 ), which can be attributed to an enhanced p-p interaction with the aromatic residues in the binding sites. [8] Therefore,wefocused on those compounds that induced an anisotropy decrease equal or greater than 20 %, or resulted in protein precipitation, as well as appearing synthetically accessible and water-soluble (Supporting Information, Table S2 ).
We then assayed the selected EBAs on bacterial cultures of both non-capsulated (R6) and type-2 capsulated (D39) pneumococcal strains.M ost of the EBAs tested, and especially those with the tertiary amine (see below), arrested cellular growth at 1mm concentration, causing bacterial lysis in many cases ( Figure 1 , see Table 1f or select compounds; Supporting Information, Figures S2, S3, Table S2 ). It is worth noting that bacterial lysis was preceded by ac hange in cell appearance consisting of a" white" phenotype while the overall shape was conserved (Figure 1b ;S upporting Information, Figure S4 ). In contrast, 10 mm atropine did not produce any detectable effect. Furthermore,cellular viability substantially decreased to various extents when the cultures were challenged with the EBAs (Table 1 ; Supporting Information, Table S2 ). This suggests that the stronger apparent binding of these molecules to the CBPs in vitro as compared to atropine or ipratropium (Supporting Information, Figure S1 ) is also translated into am ore effective antimicrobial behavior.
Thenegative effect of EBAs on pneumococcal growth and viability is observed both in non-virulent, non-capsulated (R6) and in capsulated (D39) strains (Tables 1; Supporting Information, Figures S2, S3 ), although the antibacterial efficiency is somehow diminished in the latter.T his is as trong indication that EBAs might be applied as antimicrobials to all virulent strains independent of their capsular type.MICs are in the micromolar range for both strains (Table 1; Supporting  Information, Table S2 ). This represents a2 -3 magnitudeorder improvement over the 1-ring starting compounds atropine and ipratropium, with MICs in the range of 12-15 mm.
[5b] Them ost effective compounds,a sd efined by the lowest MIC on D39 and causing the highest decrease on cell viability at the lowest concentration, are 18, 26, 27,a nd 31 (Scheme 1).
To evaluate the capacity of EBAs to specifically inhibit CBPs,t he selected compounds were checked for in vitro inhibition of the LytA amidase (Table 2) . These molecules diminished enzymatic activity at much lower concentrations than choline (IC 50 = 9.1 mm)a nd atropine (IC 50 = 4.5 mm). Remarkably, 31 evidenced the highest inhibition capacity (IC 50 = 0.1 mm), representing a4 5-fold improvement over atropine.O nt he other hand, simultaneous addition of 31 (final concentration = 0.1 mm)a nd excess choline (150 mm) to R6 and D39 cultures led to as ubstantial reduction of bacterial lysis concomitant with an increase in viability (Supporting Information, Table S3 ), indicating that high choline concentrations may partially revert EBAb inding to CBPs. . .
Them ost efficient compounds both in terms of cell lysis and viability loss correspond (on an equal aromatic moiety) to tertiary,b icyclic amines (Supporting Information, Table S2 ). Non-bicyclic amines display diminished binding to C-LytA (Supporting Information, Figure S1 ), which can be ascribed to the lower ligand surface burial and decreased van der Waals interactions.I nc ontrast, quaternary amines,t hough better binders in vitro (Supporting Information, Figure S1 ), show poorer results,probably owing to reduced availability in vivo.
To further investigate the molecular basis of EBAbinding, we carried out adetailed C-LytA-GFP anisotropy-monitored titration with some representative compounds (Supporting Information, Figure S5 ). All of the molecules induced as igmoidal transition. Addition of choline and atropine led to final anisotropy values of around 0.28, representing the formation of protein dimers. [6a] Nevertheless,m ost of the EBAs decreased the anisotropies to much lower values, suggesting am assive energy transfer between GFP moieties as ac onsequence of protein association and eventual precipitation. Such aggregates are EBA-specific as addition of an excess choline (150 mm)d isplaced the bound EBAs, resolubilizing the protein, and restoring the anisotropies to dimer values around 0.28 (data not shown). Next, we performed ad ocking simulation of the binding of 31,t he EBAd isplaying the highest inhibitory effect, to C-LytA. We then selected, among the most stable conformations,t hose with binding modes similar to experimental CbpF-atropine complexes,t hat is,d isplaying favorable T-shaped p-p interactions with the aromatic residues in the binding sites. [8] The bulky aromatic moiety of EBAs would generate extensive solvent-exposed non-polar patches that easily favor intermolecular aggregation (Supporting Information, Figure S6 a, b) .
Thef inal oligomeric state at the end of the titration is undefined and certainly different among EBAs (Supporting Information, Figure S5 ). Therefore,b inding curves were not subjected to thermodynamic analysis and, thus,w ew ill refer to apparent affinities from this point on. To evaluate the relative binding strengths,w ec hose the minimal ligand concentration required to achieve an anisotropy value of 0.28 (representative of soluble dimers,a ss tated above) as ap arameter of binding efficiency.Adirect correlation between EBAa pparent binding affinity and bacterial MICs was observed (Supporting Information, Figure S5 b, Table S4 ), suggesting that fluorescence experiments constitute asuitable approach to explain the antimicrobial behavior of EBAs.T ob etter characterize the binding,w ea lso carried out surface plasmon resonance experiments that yielded poor signals,m ost probably owing to the low molecular weight of the ligands (data not shown). On the other hand, several representative EBAs were subjected to docking procedures using the C-LytA choline-binding site configured by repeats 4 and 5( CBR4-5 site), and responsible for protein dimerization, as at arget (Supporting Information, Figure S6 and Table S4 ). [9] These data, together with those shown in Figure S5 (Supporting Information) , suggest that binding of EBAs depends on several factors,n amely polarity,n umber and geometry of aromatic rings,a nd buried protein surface. Thus,t he binding of three-ringed 30 and 31 could be most favored as they optimize these aspects (see the Supporting Information, Figure S5c) . Their three adjacent aromatic rings configure an extensive interaction area (Supporting Information, Table S4 ) capable of establishing strong van der Waals contacts and T-shaped p-p interactions with the aromatic residues in the binding site.M oreover,t he flatness of the aromatic system creates as mooth hydrophobic patch on the protein surface (Supporting Information, Figure S6 Remarkably,heterocyclictwo-ring compounds 21, 22,and 23 displayed only discrete changes in C-LytA-GFP anisotropy (Supporting Information, Figures S1 and S5 a) . Heterocycle polarity has been described to decrease the strength of Tshaped p-p interactions in favor of parallel displaced interactions, [10] and is also likely to decrease hydrophobic protein-protein associations.Accordingly,heterocyclic EBAs exert al imited antipneumococcal effect (Supporting Information, Figure S2 and Table S2 ).
To validate the bactericidal results of EBAs,weemployed az ebrafish embryo model of infection. [11] Them ost appropriate bacterial challenge dose causing 50 %m ortality after 5days was found to be 2.5 10 8 cfu mL À1 for pneumococcal strain D39, when administered by immersion. Seven hours after bacterial challenge,e mbryos were treated with as ingle dose containing different amounts of 31,orphosphate buffer as control, and this operation was repeated for the first three days.E mbryo survival was followed over 5days and the results of three experiments were combined and represented as aM antel-Cox curve (Figure 2) . Rescue of the treated embryos was almost total, reaching 97.9 %survival (47/48) at 2 mm3 31 1,a nd 93.7 %( 45/48) with 1 mm,i ndicating the great efficiency of 31 to protect zebrafish embryos from pneumococcal infection.
In vitro MICs of EBAs are in the micromolar range (Table S2) . Theb est compound (31)s hows aM IC of 22 mm, comparable to usual b-lactam, macrolide,a nd fluoroquinolone antibiotics (1-12 mm). [12] Nevertheless,w ea imed to further diminish EBAfunctional concentrations by increasing their affinity for CBPs through their multivalent display on poly(propylene imine) dendrimers.Previously,wefound that choline dendrimers inhibit CBP activity more efficiently than free choline,b ut without affecting cell viability. [6a,7] To transform this non-lethal response into am ore aggressive one,a nd as ap roof-of-concept, we synthetized as econd generation PPI dendrimer, termed g2-dendropine (Scheme 1b), containing eight copies of 2b,aderivative of phenylacetyltropine (2)containing afive-carbon spacer (Supporting Information, Scheme S1). Phenylacetyltropine is ah ydroxymethyl-lacking atropine analogue that displays only amodest C-LytA-GFP binding (Supporting Information, Figure S1 ). Since the 3-OH group in atropine does not participate in CBP binding, [8] this position seemed suitable to hold afive-carbon link for the attachment to the PPI scaffold. Moreover, phenylacetyltropine binds to the muscarinic acetylcholine receptors with diminished affinity compared to atropine,s o that its antimuscarinic activity is drastically reduced to amere 0.3 %, [13] decreasing undesirable side-effects in an eventual therapeutic administration of this or related dendrimers.
Compound 2b binds to C-LytA with al ower apparent affinity than atropine and is inefficient in causing cell lysis at a1m m concentration (Supporting Information, Figures S2 a  and S5 a) , probably because of steric hindrances by the carbon spacer. Nevertheless,m ulticopy display of 2b on the PPI dendrimer greatly enhances its apparent binding affinity to CLytA-GFP (Supporting Information, Figure S7 ) as well as its LytA inhibitory efficiency in vitro,w ith an IC 50 in the nanomolar range (Table 2) , that is,a round 45 000-fold lower than atropine.
[5b] Despite atropine being abetter CBP binder than choline,
[5b] the IC 50 of g2-dendropine (100 nm) (Table 2 ) is similar to that of the previously described choline dendrimer g2-cho (200 nm), marking the limit of multivalency effects of this system. However,w hile g2-cho only induces chain formation without affecting cell viability, [6, 7] ac oncentration of g2-dendropine as low as 1 mm (8 mm in atropine equivalents) is sufficient to completely abolish growth of the R6 strain, while cellular viability is negligible at 10 mm (Figure 3 ).
Furthermore,g2-dendropine was able to arrest the growth of ah ighly pathogenic,l evofloxacin-resistant, pneumococcal clinical isolate (strain AR33118, serotype 3), albeit at ahigher concentration (10 mm) (Figure 3a,b) . To check the kinetics of this antimicrobial effect, cell viability was assessed upon challenge with 10 mm g2-dendropine for different times.A n incubation as short as 15 min is enough to decrease viability by 10-fold, both for R6 and AR33118, and after 2hvirtually all cells became non-viable (Figure 3c) . Likewise,c lear morphological changes are quickly visible,r esulting in a" white" phenotype ( Figure 3d )s imilar to that described above for 31 (Figure 1b ;Supporting Information, Figure S4 ).
In conclusion, we have demonstrated the validity of two complementary approaches to design new antipneumococcal drugs targeting the bacterial CBPs.T he best results were observed with tertiary amine EBAs with at least two nonheterocyclic, aromatic rings.Adramatic enhancement in apparent affinity can also be achieved by the display of EBAs on amultivalent dendrimer.Judicious combination of further EBAd erivatives with multivalent nanoparticles may render novel complexes with antipneumococcal properties that help fight current resistances to antibiotics.
